Viking Therapeutics Inc (VKTX)
Who owns Viking Therapeutics Inc (VKTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 97.6% of the shares are freely tradable; institutional investors hold 64.5%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Group Inc | 8.62 | 9,984,487 | -0.1 | 12/31/2025 |
| BlackRock Inc | 5.94 | 6,880,290 | +4.1 | 03/31/2026 |
| FMR Inc | 5.20 | 6,024,753 | -8.1 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.33 | 5,012,502 | +0.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 3.85 | 4,464,298 | +0.0 | 03/31/2026 |
| Two Sigma Investments LLC | 3.82 | 4,432,142 | +82.0 | 03/31/2026 |
| State Street Corp | 3.79 | 4,395,557 | -1.1 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 2.60 | 3,013,928 | -2.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 3.04 | 3,518,740 | +0.3 | 04/30/2026 |
| State Street® SPDR® S&P® Biotech ETF | 2.26 | 2,622,779 | -0.6 | 05/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 29. Jul 2026 | Lian Brian | President & CEO | Sell | 148,517 | 33.32 | 4,947,888 |
| 29. Jul 2026 | Zante Greg | Chief Financial Officer | Sell | 21,217 | 33.47 | 710,141 |
| 29. Jul 2026 | Mancini Marianna | Chief Operating Officer | Sell | 18,217 | 33.47 | 609,636 |
| 28. Jul 2026 | Lian Brian | President & CEO | Other | 221,667 | 0.00 | – |
| 28. Jul 2026 | Zante Greg | Chief Financial Officer | Other | 31,667 | 0.00 | – |
| 28. Jul 2026 | Mancini Marianna | Chief Operating Officer | Other | 31,667 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.